Clinical Trial Update: Clinical Trial of Mesenchymal Stem Cells in the Treatment of Severe Acute Kidney Injury [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial investigating mesenchymal stem cells for severe acute kidney injury across Phase 1 and Phase 2 stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Acute Kidney Injury, Mesenchymal Stem Cells | Phase 1, Phase 2 | Status: UNKNOWN